Quality of life for long-term breast cancer survivors is not affected by ethnicity, according to a recent study that appeared in the journal Cancer.
Quality of life for long-term breast cancer survivors is not affected by ethnicity, according to a recent study that appeared in the January 15th issue of Cancer.
Researchers examined the relationship between ethnicity and quality of life for 278 breast cancer patients, 117 of whom were black and 161 of whom were white. Overall, the study found that long-term breast cancer survivors had a good quality of life and viewed their health to be as good as women who did not have cancer or other life-threatening illnesses.
The study examined physical, psychological, social and functional well-being. Researchers asked participants about their life stress levels and health perceptions. Women who had better health perceptions, fewer stress factors, higher incomes, more education and partners enjoyed a higher quality of life, regardless of race.
"Race seems to play no role in determining the quality of life for long-term breast cancer survivors. However, socio-ecological factors, such as life stress, having a partner and levels of education and income were shown to be more relevant," said study co-author Kimlin Ashing-Giwa. "It's not a matter of race, it's a matter of context." PR
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.